Operating profit turned positive but PBT collapsed NZ$3.6m to a loss

What changed

Revenue was effectively flat at NZ$6.6m (+0.7% on the like-for-like total revenue basis). The reported segment result improved at the operating level, with operating profit swinging from -NZ$0.1m to +NZ$0.3m. Below that, however, the picture inverted: PBT moved from +NZ$0.3m to -NZ$3.2m, and NPAT from +NZ$0.3m to -NZ$3.2m. Continuing operations contributed -NZ$3.1m of the loss, with a further -NZ$0.1m discontinued-operations loss (FY22: -NZ$0.3m) on top.

Cash quality and balance-sheet capacity weakened in tandem. Operating cash outflow widened more than five-fold to -NZ$0.5m (FY22: -NZ$0.1m). Cash on hand fell to NZ$0.4m from NZ$1.2m, gross borrowings eased modestly to NZ$3.1m, but net debt still rose to NZ$2.7m from NZ$2.1m. Total equity dropped 53.9% to NZ$1.4m, and no dividend was declared.

What matters

• The disappearing margin between operating profit and PBT. A ~NZ$3.5m gap between the +NZ$0.3m operating profit and the -NZ$3.2m PBT is the central anomaly in this release. The supplied excerpts do not itemise the below-operating-line charges, so the PBT collapse is mechanically larger than the operating-line improvement. Until that bridge is disclosed, headline operating profit cannot be taken as the relevant earnings read.
• H2 deterioration versus HY23 commentary. Management said at HY23 that "full year revenue and profit on track to meet expectations" on an NPAT of +NZ$0.1m. The FY23 outturn implies an H2 NPAT of roughly -NZ$3.3m. That is a material reversal of stated trajectory.
• Balance-sheet headroom is thin. Equity is now NZ$1.4m and cash NZ$0.4m, against NZ$3.1m of gross borrowings. With operating cash flow still negative and worsening, the funding cushion for further loss-making periods is limited.

Expectations

The only forward signal in the supplied material was HY23's qualitative "on track" comment; no FY24 guidance, work-on-hand, or quantitative target was disclosed. Against that signal, FY23 missed clearly at the bottom line. The release does and does not support the same things: it supports the read that UK & IRE franchising remains the durable revenue engine (~96% of group revenue, ~21% inferred segment margin), but it does not support the "on track" framing implied at the half year.

Quality of result

The durable parts of the result are concentrated in UK & IRE franchising, which delivered NZ$1.3m of segment result on NZ$6.4m of revenue, and the small Global Franchising & Retail unit (~37% inferred segment margin). The drags are also visible: the New Zealand segment generated zero revenue and a -NZ$1.2m result, very similar to FY22.

The cash quality has deteriorated materially. Operating cash outflow worsened to -NZ$0.5m even as the operating result improved, and the divergence between segment operating profitability and group cash generation is wider than last year. Receivable days were broadly stable at ~73 days, so the cash deterioration is not primarily a debtor-stretch story; it points to costs absorbed below the segment result line. The 53.9% equity reduction and ROE swing from +11.1% to -226.8% are balance-sheet-confirming, not balance-sheet-flattering.

Unresolved

• What is the composition of the ~NZ$3.5m of charges between operating profit and PBT? Finance costs, impairments, fair-value items and one-offs are not split in the supplied excerpts.
• Why did H2 diverge so sharply from the HY23 "on track" framing, and is that divergence cash or non-cash in nature?
• What is the path for the New Zealand segment, which has now consumed roughly NZ$1.1–1.2m of group earnings in each of the last two years on negligible revenue?
• With cash at NZ$0.4m and operating cash flow still negative, what is the funding plan into FY24? No capex, free cash flow or net-debt facility headroom is disclosed.

This briefing cannot assess the specific drivers of the loss below the operating-profit line or any FY24 outlook, because neither was disclosed in the supplied extraction.

Key metrics

Segment breakdown

Analytical metrics

---

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.